SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities.

• Egile Nagusiak: Hannah Hussey (Egilea), Helena Vreede (Egilea), Mary-Ann Davies (Egilea), Alexa Heekes (Egilea), Emma Kalk (Egilea), Diana Hardie (Egilea), Gert van Zyl (Egilea), Michelle Naidoo (Egilea), Erna Morden (Egilea), Jamy-Lee Bam (Egilea), Nesbert Zinyakatira (Egilea), Chad M Centner (Egilea), Jean Maritz (Egilea), Jessica Opie (Egilea), Zivanai Chapanduka (Egilea), Hassan Mahomed (Egilea), Mariette Smith (Egilea), Annibale Cois (Egilea), David Pienaar (Egilea), Andrew D Redd (Egilea), Wolfgang Preiser (Egilea), Robert Wilkinson (Egilea), Andrew Boulle (Egilea), Nei-Yuan Hsiao (Egilea)
• Formatua: Liburua
• Argitaratua: Public Library of Science (PLoS), 2024-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

In low- and middle-income countries where SARS-CoV-2 testing is limited, seroprevalence studies can help describe and characterise the extent of the pandemic, as well as elucidate protection conferred by prior exposure. We conducted repeated cross-sectional serosurveys (July 2020 -November 2021) usi...